Group-NKTR (N=516) Group-KTR (N=194)
Total
P
Intravenous hormones, n (%) 31(6.0%) 83(42.8%) 114(16.1%) 0.000
Azvudine, n (%) 77(14.9%) 112(57.7%) 189(26.6%) 0.000
Paxlovid, n (%) 125(24.2%) 77(39.7%) 202(28.5%) 0.000
Monoclonal antibodies, n (%) 0(0.0%) 8(4.1%) 8(1.1%) 0.000
Proglobulin, n (%) 5(1.0%) 35(18.0%) 40(5.6%) 0.000
Oxygenation, n (%) 239(46.3%) 17(8.8%) 256(36.1%) 0.000
Time O to P*, d, median (IQR) 0.0(0.0,4.0) 0.0(0.0,3.0) 0.0(0.0,4.0) 0.481
Time O to N*, d, median (IQR) 9.0(12.0,16.0) 15.0(20.5,25.8) 10.0(14.0,21.0) 0.000
Time O to D*, d, median (IQR) 9.0(12.0,16.0) 18.8(24.0,29.0) 9.0(14.0,21.0) 0.000
Time O to A*, d, median (IQR) 2.0(5.0,8.0) 7.0(11.0,16.0) 2.0(6.0,10.0) 0.000
Days of hospitalization, d, median (IQR) 4.0(7.0,9.0) 8.0(11.0,16.0) 5.0(7.0,11.0) 0.000